# Topical Nepafenac as Supplement for Diabetic Macular Edema

> **NCT02443012** · PHASE4 · COMPLETED · sponsor: **Universiti Sains Malaysia** · enrollment: 47 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Topical Gutt Nepafenac 0.1%
- **PROCEDURE:** Laser

## Key facts

- **NCT ID:** NCT02443012
- **Lead sponsor:** Universiti Sains Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02443012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02443012, "Topical Nepafenac as Supplement for Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02443012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*